Latest News Archive
Please select Category, Year, and then Month to display items
01 October 2019
|
Story Xolisa Mnukwa
|
Photo Xolisa Mnukwa
From the left; Gift Taku, 2019 Doty winner; Reabetswe Mabine, Doty Coordinator Tshepo Zweni, first runner-up and Jacobeth Selinga, second runner-up
The votes have been tallied, and after much deliberation, the UFS is proud to announce Gift Taku as the winner of the 2019 KovsieGear Designer of the Year (DOTY) Competition!
Tshepo Zwane and Jacobeth Selinga won second and third place respectively, with innovative designs that complied with the assessment requirements, based on originality of the design, adherence to the brand guidelines, creativity, and other criteria.
Gift’s design triumphed with 845 votes on the UFS KovsieLife webpage, as well as in the presentation in front of a judging panel.
Since 2016, KovsieGear has been discovering local (UFS staff and students) graphic designers and giving them a platform to showcase their work through DOTY, which runs annually. The aim of the competition is to support local talent by giving entrants an opportunity to come up with creative designs that are unique to the university and which will be used on limited-edition apparel in the store, as well as getting featured in the KovsieGear catalogue.
The competition has since fashioned the best clothing-logo designs the university has ever seen and continues to motivate and empower students to make positive contributions to the Kovsie campus culture and brand.
For more information about DOTY contact Reabetswe Mabine at MabineR@ufs.ac.za
The winning design by Gift Taku:
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”